Title: Implications of genomics for the US healthcare system

Authors: Campbell Murray

Addresses: Novartis Venture Fund, One Cambridge Center, Cambridge, MA 02142, USA

Abstract: Advances in genomics have the potential to significantly improve the quality of healthcare delivery in the USA, but there are dangers inherent in some of the knowledge advances that necessitate federal government intervention in select areas of the health system. So long as diagnostic capabilities run ahead of treatment solutions, the USA|s healthcare insurance system will face pressure as advances in genomics generate greater ability to risk-stratify insurance applicants. Indeed, the advent of genomics to healthcare practice may render some people effectively uninsurable. Moreover, the loss of people from the insurance pool may cause a spiral of rising insurance premiums on a declining base, which could leave a large proportion of Americans without health insurance coverage. Thus, aside from moral considerations of equity and ensuring that all Americans have reasonable access to healthcare, it may be economically inefficient not to mandate universal coverage.

Keywords: genetics; genomics; healthcare technology; health economics; heredity; health insurance; insurance risk; predetermination; screening; healthcare delivery; USA; United States; federal government; government intervention; insurance premiums.

DOI: 10.1504/IJHTM.2007.013515

International Journal of Healthcare Technology and Management, 2007 Vol.8 No.5, pp.426 - 450

Published online: 03 May 2007 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article